Stereotactic Radiosurgery · Reference

Plan-Quality Metrics, Prognostic Scores & Constraint References

The formulas, scores, and consensus documents used at the planning station and in clinic

This page collects the quantitative tools of radiosurgical practice in one place: the plan-quality indices (conformity, gradient, coverage) used to judge a plan, the dose-modeling concepts (BED/EQD2) and their ablative-dose caveats, the prognostic scores that frame the clinical decision (GPA for brain metastases; NOMS/SINS/ESCC for spine), and the consensus constraint and contouring documents that practice rests on.

Orientation

A radiosurgery plan is judged by numbers and the clinical decision is framed by scores. Knowing what each metric measures — and its failure mode — is what separates mechanical plan evaluation from real quality control. The same applies to prognostic scores: they organize the conversation but do not replace judgment.

Part I

Plan-Quality Metrics

1.Conformity, gradient, and coverage

Three families of metrics describe how well a plan wraps dose around the target and falls off outside it:

  • Paddick conformity index (CI): rewards conformity while penalizing both under-coverage and spill. Paddick CI = (TV_PIV)² / (TV × PIV) where TV = target volume, PIV = prescription isodose volume, TV_PIV = target volume covered by the prescription isodose. CI → 1 is ideal. (The older RTOG CI = PIV / TV is simpler but does not penalize a prescription volume that misses the target.)
  • Gradient index (GI): how fast dose falls off outside the prescription — the key to sparing normal brain. GI = PIV_half / PIV the volume of half the prescription isodose divided by the prescription isodose volume; lower is steeper/better.
  • Coverage and homogeneity: coverage = fraction of target receiving the prescription; homogeneity index describes dose uniformity within the target (note that SRS often deliberately accepts a hot, inhomogeneous interior).

2.Dose modeling: BED and EQD2 (with a caveat)

Biologically effective dose and the 2-Gy-equivalent dose let schedules be compared, but at ablative fraction sizes the underlying linear-quadratic model is contested:

BED = n × d × [1 + d / (α/β)]   EQD2 = BED / [1 + 2 / (α/β)]

where n = number of fractions, d = dose per fraction. These are reliable in the conventional range but should be used cautiously above the SRS dose-per-fraction threshold, where the model may overestimate effect — the reason empirical trial doses (RTOG 90-05, HyTEC) guide SRS prescribing rather than pure BED extrapolation.

Part II

Prognostic and Decision Scores

3.Brain metastases: the GPA

The Graded Prognostic Assessment (GPA) and its diagnosis-specific and molecular updates (ds-GPA, and disease-specific GPAs incorporating, e.g., EGFR/ALK in lung, HER2 in breast, BRAF in melanoma) estimate survival from factors such as age, performance status, number of metastases, extracranial disease, and tumor-specific molecular markers. Its role is to match treatment intensity to expected survival — aggressive local therapy and cognition-sparing strategies make sense in longer-prognosis groups, comfort-weighted approaches in the shortest.

4.Spine: NOMS, SINS, ESCC

For spinal disease the relevant scores are the NOMS framework (Neurologic/Oncologic/Mechanical/Systemic), the SINS (Spinal Instability Neoplastic Score), and the Bilsky ESCC epidural compression grade — developed in detail on the spine foundations page. Together they decide SBRT versus separation surgery versus stabilization versus conventional RT.

Part III

Constraint and Contouring References

5.The documents practice rests on

Key consensus and reference documents (use the current published version adopted by your center).
DocumentScope
AAPM MPPG 9.bCurrent minimum physics practice guidance for linac-based SRS/SBRT programs
AAPM TG-178Gamma stereotactic radiosurgery calibration, dosimetry, mechanical QA, and treatment-process QA
AAPM TG-101SBRT physics, prescribing, quality assurance, normal-tissue constraints
AAPM TG-142 / TG-135Linac QA; CyberKnife (robotic) QA
QUANTECNormal-tissue dose-response (conventional baseline; cord, optic, brainstem)
HyTECHypofractionated/SRS-specific tumor-control and normal-tissue dose-response
RTOG 90-05Single-fraction maximum tolerated dose by lesion size
ISRS consensus / consortium contouringCranial and spine target-volume delineation guidelines
Cox et al. (spine consortium)Spine SBRT target-volume consensus
Use the live version Constraint values, MTDs, and contouring guidance are periodically updated, and individual centers adopt specific constraint sets. Treat the documents above as the canonical sources and always apply the current version your physics and radiation-oncology team have adopted — not numbers from memory or from a single page.

Key points

  • Paddick CI = (TV_PIV)²/(TV×PIV) penalizes both miss and spill; RTOG CI = PIV/TV does not. Gradient index = PIV_half/PIV measures fall-off (lower = steeper).
  • BED/EQD2 compare schedules but are unreliable at ablative fraction size — lean on empirical trial doses (RTOG 90-05, HyTEC), not LQ extrapolation.
  • GPA (and molecular ds-GPA) matches treatment intensity to expected survival in brain metastases.
  • Spine decisions run on NOMS + SINS + ESCC together.
  • MPPG 9.b, TG-178, TG-101, QUANTEC, HyTEC, RTOG 90-05, and consensus contouring guidelines are the canonical references — always use the current adopted version.

References

  1. Paddick I. A simple scoring ratio to index the conformity of radiosurgical treatment plans. J Neurosurg. 2000;93(Suppl 3):219–222. PubMed
  2. Benedict SH, Yenice KM, Followill D, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys. 2010;37(8):4078–4101. PubMed
  3. Milano MT, Grimm J, Niemierko A, et al. Single- and multifraction stereotactic radiosurgery dose/volume tolerances of the brain (HyTEC). Int J Radiat Oncol Biol Phys. 2021;110(1):68–86. PubMed
  4. Cirino E, Benedict SH, Dupre PJ, et al. AAPM-RSS Medical Physics Practice Guideline 9.b: SRS-SBRT. J Appl Clin Med Phys. 2025. AAPM
  5. Petti PL, Rivard MJ, Alvarez PE, et al. Recommendations on the practice of calibration, dosimetry, and quality assurance for gamma stereotactic radiosurgery: report of AAPM Task Group 178. Med Phys. 2021. AAPM
  6. Sperduto PW, Mesko S, Li J, et al. Survival in patients with brain metastases: summary report on the updated diagnosis-specific GPA and definition of the eligibility quotient. J Clin Oncol. 2020;38(32):3773–3784. PubMed
  7. Cox BW, Spratt DE, Lovelock M, et al. International spine radiosurgery consortium consensus guidelines for target volume definition. Int J Radiat Oncol Biol Phys. 2012;83(5):e597–e605. PubMed

Educational reference for neurosurgery and radiation-oncology trainees; not a treatment directive. Formulas and document scopes are summarized; apply the current adopted version of each constraint/contouring reference. Citation anchors verified during review.